SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

Share Price is delayed by 15 minutes
Get Live Data
295.80    10.40 (3.64%)
Bid:
296.80
Ask:
297.40
Spread: 0.60 (0.202%)
Market Cap: £1.03b
BREE Live PriceLast checked at - London Stock Exchange

Intraday Breedon Share Chart

Board Changes

2 Dec 2019 07:00

RNS Number : 2201V
Breedon Group PLC
02 December 2019
 

 

 

 

2 December 2019

 

Breedon Group plc ("Breedon")

Board Changes

 

Breedon Group plc, a leading construction materials group in Great Britain and Ireland, has appointed Moni Mannings as an independent non-executive director with effect from 1 December 2019.

 

Moni has held several senior non-executive positions, including as a Board Member of the Solicitors Regulation Authority, non-executive director of Dairy Crest Group PLC and non-executive director and Chair of the Remuneration Committee of Polypipe Group PLC. She is currently Senior Independent Director and Chair of the Remuneration Committee of Investec Bank PLC.

 

Moni is a former Partner and Head of the International Banking & Finance Division of Olswang LLP, prior to which she held senior positions with Dewey Ballantine LLP and Simmons & Simmons. More recently, she was Chief Operating Officer of Aistemos Ltd, a leading IP data analytics and strategy company.

 

Having served on the Board of Breedon since its creation in 2008, David Williams will retire as a director on 31 December 2019. The Board would like to express its thanks to David for his support and counsel during the development of the Breedon Group. It is anticipated that Moni will succeed him as Chair of Breedon's Remuneration Committee upon his retirement.

 

David Williams commented: "Having served as a non-executive director and Chair of the Remuneration Committee since co-founding the company in 2008, I believe the time is now right to step down from the Board in accordance with best governance practice. I will therefore retire as a director at the end of this year. It has been an absolute pleasure to serve on Breedon's Board for the last 11 years and as I take my leave I am delighted that the company has attracted two such outstanding new non-executive directors in Moni Mannings and Clive Watson. I wish the company and its staff every success in the future."

 

Regulatory Disclosures

In the previous five years, Sheikh Mansurah Tal-At (Moni) Mannings (née Ahmad), aged 56, has been a director of the following entities:

 

Current directorships

Past directorships

Barnardo's, Charity

Investec Bank PLC

Investec Holdings (Ireland) Limited

Investec Europe Limited

The Felix Dennis Foundation, Charity

The St Marks Hospital Foundation, Charity

Aistemos Limited

BFWG Charitable Foundation

CMS Cameron Mckenna Nabarro Olswang (Singapore) LLP

Cranfield University

Dairy Crest Group PLC

Funds for Women Graduates, Charity

Investec Capital and Investments (Ireland) Limited

Olswang LLP

Olswang France LLP

Olswang Spain LLP

Polypipe Group PLC

Solicitors Regulation Authority

 

As at today's date, Ms Mannings does not hold any ordinary shares in Breedon.

 

There are no other details regarding the appointment of Ms Mannings that require disclosure under Schedule 2(g) of the AIM Rules for Companies.

 

- ends -

 

Note to editors

 

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. The Group employs nearly 3,000 people and has nearly 900 million tonnes of mineral reserves and resources. Its strategy is to continue growing organically and through the acquisition of businesses in the heavyside construction materials market.

 

 

 

For further information:

 

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director 01332 694010

 

Stephen Jacobs, Head of Communications 07831 764592

 

Cenkos Securities (NOMAD and Joint Broker)

Max Hartley / Harry Hargreaves 020 7397 8900

 

Numis (Joint Broker)

Ben Stoop / Heraclis Economides 020 7260 1000

 

Teneo

Matt Denham / Rachel Miller 020 7420 3180

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOABLBFTMBITBBL
Date   Source Headline
17th Jul 202512:37 pmRNS-RNotice of live interactive presentation on Engage
30th Jun 20257:00 amRNSTotal Voting Rights
30th Jun 20257:00 amRNSBlock Listing Six Monthly Return
27th Jun 20254:10 pmRNSHolding(s) in Company
24th Jun 20251:00 pmRNSNotice of Interim Results
16th Jun 20254:42 pmRNSDirector/PDMR Shareholding
30th May 20259:41 amRNSTotal Voting Rights
6th May 20252:15 pmRNSHolding(s) in Company
2nd May 20253:34 pmRNSDirector/PDMR Shareholding
30th Apr 202512:46 pmRNSTotal Voting Rights
29th Apr 20254:55 pmRNSResult of AGM
29th Apr 20257:00 amRNSAGM Trading Update
17th Apr 20253:24 pmRNSHolding(s) in Company
15th Apr 20251:27 pmRNSDirector/PDMR Shareholding
15th Apr 20259:25 amRNSHolding(s) in Company
15th Apr 20259:23 amRNSHolding(s) in Company
9th Apr 20253:31 pmRNSHolding(s) in Company
8th Apr 20255:16 pmRNSDirector/PDMR Shareholding
8th Apr 20255:15 pmRNSDirector/PDMR Shareholding
31st Mar 20253:23 pmRNSTotal Voting Rights
26th Mar 20252:34 pmRNSHolding(s) in Company
17th Mar 202510:10 amRNS2024 Annual Report and Notice of AGM
12th Mar 20253:35 pmRNSApplication for Admission of Consideration Shares
7th Mar 20257:00 amRNS-RLive presentation via Investor Meet Company
6th Mar 202512:00 pmRNSCompletion of Acquisition
5th Mar 20257:01 amRNSAcquisition
5th Mar 20257:00 amRNSFinal Results
28th Feb 20251:56 pmRNSTotal Voting Rights
4th Feb 20259:25 amRNSNotice of Results
31st Jan 20257:00 amRNSTotal Voting Rights
31st Dec 20247:00 amRNSBlock listing six monthly return
31st Dec 20247:00 amRNSTotal Voting Rights
2nd Dec 20244:40 pmRNSDirector/PDMR Shareholding
29th Nov 20249:15 amRNSTotal Voting Rights
21st Nov 20247:00 amRNSNovember Trading Statement
12th Nov 20245:06 pmRNSDirector/PDMR Shareholding
31st Oct 20247:00 amRNSTotal Voting Rights
30th Sep 20241:55 pmRNSTotal Voting Rights
30th Aug 20248:49 amRNSTotal Voting Rights
31st Jul 202410:11 amRNSTotal Voting Rights
24th Jul 20247:00 amRNSInterim results 2024
11th Jul 20244:33 pmRNSHolding(s) in Company
28th Jun 20247:00 amRNSBlock listing six monthly return
28th Jun 20247:00 amRNSTotal Voting Rights
25th Jun 20242:38 pmRNSNotice of Results
13th Jun 20243:53 pmRNSDirector/PDMR Shareholding
12th Jun 20245:16 pmRNSHolding(s) in Company
12th Jun 20244:31 pmRNSDirector/PDMR Shareholding
11th Jun 20244:28 pmRNSHolding(s) in Company
6th Jun 20242:56 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.